CommercialCoverageMedium impact
Varicose Vein Treatments 7.01.47
Excellus BlueCross BlueShield·Vascular Surgery, General Surgery, Dermatology·Cosmetic / Reconstructive Surgery
Effective date
Oct 16, 2025
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield has updated their varicose vein treatment policy effective October 16, 2025, establishing specific medical necessity criteria including required ultrasound documentation of saphenous reflux ≥500ms, CEAP class C2 or greater, and mandatory 3-month conservative treatment trial for symptomatic cases. Several treatment methods are now classified as investigational and not covered.
Action Required
Before October 16, 2025: Billing team must update pre-authorization requirements for varicose vein treatments to verify saphenous reflux ≥500ms via duplex ultrasound, CEAP classification C2+, and 3-month conservative treatment documentation. Stop billing CPT 0542T, 36473, and 36474 as these are now investigational. Update encounter forms to remind providers of required documentation elements.